Digital mental health platform Cerebral announced it's letting go of 15% of its workforce in its third round of layoffs since last summer.
In a LinkedIn post, the company's CEO David Mou confirmed the layoffs, saying the reduction was a business decision to align with company needs and not associated with individual performance.
"As a young company, we grew quickly to support a rapidly growing...
Bipartisan senators sent letters to telehealth providers Monument, Workit Health and Cerebral urging the companies to better protect users' healthcare data.
Sens. Amy Klobuchar (D-Minn.), Susan Collins (R-Me.), Maria Cantwell (D-Wa.) and Cynthia Lummis (R-Wyo,) expressed concerns that the companies are "tracking and sharing sensitive and personally-identifiable health data with third-party...
Cerebral is suing its ousted cofounder Kyle Robertson, alleging he never repaid a loan received from the digital mental health company.
According to a lawsuit filed last week in New York, Cerebral said Robertson defaulted on a nearly $50 million loan that he took out in January to buy 1.06 million shares of common stock in the company. Cerebral alleges Robertson is personally liable for more...
Embattled digital mental health company Cerebral will lay off about 20% of its staff as it restructures its business, according to reporting by The Wall Street Journal.
A memo from CEO Dr. David Mou that was reviewed by the WSJ said the cuts would affect employees across the company, including at headquarters and among clinical care staff and support workers.
A Cerebral spokesperson said the...
Digital mental health company Cerebral is under investigation by the Federal Trade Commission, according to a letter sent by the agency and reviewed by the Wall Street Journal.
According to WSJ, the FTC is investigating whether Cerebral was involved in deceptive or unfair marketing or advertising practices, including raising questions about programs where the virtual mental health company...
In the midst of controversy surrounding the digital mental health company's prescribing practices and a week after it replaced its CEO, Cerebral revealed a transformation plan focused on growth and patient experience.
The program, called Cerebral Core, includes objectives to review quality practices as well as improve the user and clinician experience.
The company said it plans to add in-network...
Cerebral CEO and cofounder Kyle Robertson is leaving his position at the digital mental health company amid growing controversy over its prescribing practices, particularly for controlled substances like Adderall.
Dr. David Mou, who has served as Cerebral's president and chief medical officer, will be taking the reins as CEO effective immediately. Mou added the president role earlier this month....
Cerebral will stop prescribing most controlled substances to new and existing patients, the embattled digital mental health company confirmed to Insider.
According to an email sent to staff on Monday, Cerebral CEO Kyle Robertson said the company would halt prescriptions of controlled substances like Adderall and Xanax for new patients starting May 20 and for existing patients starting October 15...
Cerebral is under investigation for possible violations of the Controlled Substances Act as the digital mental health company faces increasing scrutiny over its prescribing practices for medications like Adderall.
As first reported by Insider, Cerebral confirmed it had received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York on the evening of May 4. That...
Amid growing controversy over Cerebral's prescribing practices, the digital mental health company will pause prescriptions of controlled substances like Adderall and Ritalin for new patients.
The suspension will begin Monday, May 9, though existing patients can continue to receive their prescribed medications.
"It is regrettable that a helpful class of medication that is considered a first-line...
